近日, 北京中医药大学万瑾毅副研究员、姚海强副研究员与芝加哥大学Chun-Su Yuan终身讲席教授团队合作,在国际顶尖医学期刊《英国医学杂志》(BMJ)发表了题为:Comparative effectiveness of GLP-1 receptor agonists on glycemic control, body weight, and lipid profile for type 2 diabetes: systematic review and netwo...
近日,北京中医药大学万瑾毅副研究员、姚海强副研究员与芝加哥大学Chun-Su Yuan终身讲席教授团队合作,在国际顶尖医学期刊《英国医学杂志》(BMJ)发表了题为:Comparative effectiveness of GLP-1 receptor agonists on glycemic control, body ...
[8].Look AHEAD Research Group, Gregg EW, Jakicic JM, et al. Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical...
GLP-1 analogs useful for diabetes treatmentUS5545618 * 1993年12月10日 1996年8月13日 Buckley; Douglas I. GLP-1 analogs useful for diabetes treatmentWO1991011457A1 * Jan 24, 1991 Aug 8, 1991 Douglas I Buckley Glp-1 analogs useful for diabetes treatment...
近日,北京中医药大学万瑾毅副研究员、姚海强副研究员与芝加哥大学Chun-Su Yuan终身讲席教授团队合作,在国际顶尖医学期刊《英国医学杂志》(BMJ)发表了题为:Comparative effectiveness of GLP-1 receptor agonists on glycemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network...
People taking a popular type of drug for weight loss or to manage diabetes have a lowerlikelihoodof being newly diagnosed withdepression or anxiety, according to an analysis of millions of people's health records. likelihood:可能性 depression or anxiety:抑郁症或焦虑症 ...
[2] Finan, B., Yang, B., Ottaway, N., Smiley, D.L., Ma, T., Clemmensen, C., et al. 2015. Arationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents.Nat Med 21:27-36. [3] Finan, B., Yang, B., Ottaway, N., Stemmer, K., Muller, T.D.,...
but there’s off-label use of these agents in people with type 1 diabetes for managing weight. One study presented at the meeting found that 18% of young people with type 1 diabetes who had severe obesity and 34%...
近日,北京中医药大学万瑾毅副研究员、姚海强副研究员与芝加哥大学Chun-Su Yuan终身讲席教授团队合作,在国际顶尖医学期刊《英国医学杂志》(BMJ)发表了题为:Comparative effectiveness of GLP-1 receptor agonists on glycemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network...
and safety of once weekly semaglutide 2.4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial.Lancet Diabetes Endocrinol. Mar 2024;12(3):184-195. doi:10.1016/S2213-8587(23)00388-1 ...